Scientists demonstrate for the first time in a mouse model that skeletal muscle cells cultured in a low-calorie environment refrain from differentiating, an energy-demanding process by which cells mature and specialize.
Ads by Google
It has long been known that type 2 diabetes is linked to obesity, particularly fat inside the belly. Now, researchers at the Joslin Diabetes Center have found that fat from other areas of the body can actually reduce insulin resistance and improve insulin sensitivity.
In a study published in the May issue of Cell Metabolism, a team lead by C. Ronald Kahn, M.D. found that subcutaneous fat -- fat found below the skin, usually in the hips and thighs -- is associated with reduced insulin levels and improved insulin sensitivity.
A new study examining the dose accuracy of the SoloSTAR disposable insulin pen for diabetes patients, prefilled with Lantus or Apidra, found the pens accurately delivered all insulin doses within standard limits defined by the ISO.
Teens with Type 1 Diabetes often use Insulin pumps as part of treating the disease but an FDA study shows the device has been linked to injuries and a few deaths.
A highly detailed mathematical simulation model can help people with undiagnosed diabetes identify whether they likely have the disease and can predict ways for dramatically reducing the costs and complications associated with this now epidemic illness.
Researchers at Children's Research Institute recently made significant discoveries in juvenile diabetes diagnosis. Led by Martin Hessner, PhD, associate professor, Medical College of Wisconsin, the research team applied a new approach, finding that type 1 diabetes patients during the honeymoon phase create a unique genomic fingerprint. The research team used a new type of blood test that identifies inflammation associated with type 1 diabetes though a unique genomic fingerprint. Remarkably, this fingerprint is evident years prior to disease onset.
Pelikan Technologies and Eli Lilly will promote awareness and education in the management and treatment of diabetes, including insulin therapy, insulin delivery devices and technological advancements in lancing designed to optimize Finger Health and Glucose Monitoring.
Abbott announced the availability of the FreeStyle Freedom Lite Blood Glucose Monitoring System.
Men who develop diabetes in mid-life appear to significantly increase their risk of developing Alzheimer's disease.
Tolerx is proceeding toward the initiation of a Phase III study of otelixizumab in new-onset type 1 diabetes. Tolerx is initiating this pivotal trial after reviewing the results of the otelixizumab development program with the US Food and Drug Administration (FDA) at an End of Phase II meeting.
An all-natural dietary supplement made from citrus may help people with type 2 diabetes lower their blood glucose numbers after a meal and their LDL-cholesterol levels.
While many health plan insurers will pay for patients with type 1 diabetes mellitus to have an insulin pump, the criteria for approval is not always clear.
Insulin has a previously unknown effect that plays a role in aging and lifespan, a finding that could ultimately provide a mechanism for gene manipulations that could help people live longer and healthier lives.
More than 54 million American adults have prediabetes, but many of those people may never have to live with diabetes and all of its health complications thanks to a new prediabetes lifestyle management course created by Kronos Optimal Health Company.
Data shows a 50% reduction of type 2 diabetes occurred in Japanese children following the discontinuation of a single vaccine, a vaccine to prevent tuberculosis.
CV Therapeutics's preclinical research showed that ranolazine increased glucose-stimulated insulin secretion in pancreatic islets isolated from animals and humans.
Scientists have identified six more genetic variants involved in type 2 diabetes, boosting to 16 the total number of genetic risk factors associated with increased risk of the disease.
The one-year pooled ARRIVE data for TAXUS stent confirmed the known higher mortality rate for diabetics versus non-diabetics with cardiovascular disease.
Two major eye diseases and leading causes of blindness - age-related macular degeneration and diabetic retinopathy - can be treated in mice by drugs that activate a protein found in blood vessel cells.
The VAP cholesterol test from Atherotech is helping physicians pinpoint the most effective cholesterol and heart disease risk lowering treatments in Type II diabetes patients.
It is estimated that nearly one third of Type 2 diabetes cases are unaware that they have the disease.
Two former major pharma scientists challenged the concept behind the leading treatments for type 2 diabetes, a disease that impacts millions of Americans.
Phosphagenics Limited has received ethics approval to commence treating patients with Type 1 diabetes in a Phase 2 clinical trial using its patented transdermal insulin delivery system, TPM/Insulin. The lead clinical investigators of the trial will be Dr. Michael D' Emden, Department of Endocrinology, Royal Brisbane and Women's Hospital, and William Hsu, who is an Assistant Investigator in the Section on Clinical Research at the Joslin Diabetes Centre and an Assistant Professor of Medicine at Harvard Medical School, Boston, MA.